A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma-Reference-Cited by-同舟云学术

A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma

Published:2020-01 Issue: Volume:125 Page:58-68
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Marec-Berard Perrine,Dalban Cécile,Gaspar Nathalie,Brugieres Laurence,Gentet Jean-Claude,Lervat Cyril^ORCID,Corradini Nadège,Castex Marie-Pierre,Schmitt Claudine,Pacquement Hélène,Tabone Marie-Dominique,Brahmi Mehdi,Metzger Séverine,Blay Jean-Yves^ORCID,Pérol David

Funder

Chugai Pharmaceutical

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference32 articles.

1. The adolescent and young adult with cancer: state of the art -- bone tumors;Rainusso;Curr Oncol Rep,2013

2. Multiple relapses in high-grade osteosarcoma: when to stop aggressive therapy?;Tamamyan;Pediatr Blood Cancer,2015

3. Osteosarcoma treatment - where do we stand? A state of the art review;Luetke;Cancer Treat Rev,2014

4. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS);Kempf-Bielack;J Clin Oncol,2005

5. Osteosarcoma: the COSS experience;Bielack;Cancer Treat Res,2009

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?;Cancer Treatment Reviews;2023-11

2. Prognosis of limb‑salvage treatment of osteosarcoma in adolescent patients: a meta‑analysis;Oncology Letters;2023-09-15

3. Characterization of Cell-Free DNA Size Distribution in Osteosarcoma Patients;Clinical Cancer Research;2023-02-03

4. A 3D Collagen-Based Bioprinted Model to Study Osteosarcoma Invasiveness and Drug Response;Polymers;2022-09-28

5. Favorable outcome of high-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with nonmetastatic osteosarcoma and low-degree necrosis;Frontiers in Oncology;2022-09-13